Keyphrases
Asian Patients
100%
Combined Antiretroviral Therapy (cART)
100%
Cotrimoxazole Prophylaxis
100%
Tuberculosis Risk
100%
Cotrimoxazole
100%
Tuberculosis
75%
Body Mass Index
50%
CD4 Count
50%
Tuberculosis Diagnosis
50%
Antiretroviral Therapy Initiation
50%
Tuberculosis Infection
50%
Multivariate Analysis
25%
Survival Prediction
25%
Asia
25%
Asian Cohort
25%
Follow-up Time
25%
HIV Patients
25%
Observational Cohort
25%
Incidence Rate
25%
Viral Load
25%
Mycobacterium Tuberculosis (M. tb)
25%
Malaria
25%
Duration of Therapy
25%
Preventive Effect
25%
Female Sex
25%
HIV Viral Load
25%
Cox Regression
25%
Older Adults Living with HIV
25%
Cotrimoxazole Preventive Therapy
25%
Hepatitis C Coinfection
25%
Serious Bacterial Infection
25%
Severe Immunosuppression
25%
Pneumocystis Jirovecii
25%
Medicine and Dentistry
Human Immunodeficiency Virus
100%
Trimethoprim/Sulfamethoxazole
100%
Antiretroviral Therapy
66%
Body Mass Index
33%
Tuberculosis
33%
Tuberculosis Diagnosis
33%
Multivariate Analysis
16%
Treatment Duration
16%
Bacterial Infection
16%
Hepatitis C
16%
Proportional Hazards Model
16%
Mycobacterium Tuberculosis
16%
Immunosuppressive Treatment
16%
Mixed Infection
16%
Prophylaxis
16%
Pneumocystis Pneumonia
16%
Immunology and Microbiology
Human Immunodeficiency Virus
100%
Viral Load
50%
CD4 Lymphocyte Count
50%
Body Mass
50%
Hepatitis C
25%
Coinfection
25%
Mycobacterium Tuberculosis
25%
Immunosuppression
25%
Pneumocystis Jiroveci
25%